Holistic Remedies · Ingredient
Urogastrone
Formula: C257H381N73O83S7 · MW: 6045.771999999988 · Drug-likeness: 0.007
⚗️ Identity
Name
Urogastrone
Aliases / Synonyms
Uroanthelone; Uroenterone; Urogastron; Kutrol; beta-Urogastrone; Anthelone U; Gastrone, uro-; 62229-50-9; Urogastrone [JAN]
🧪 Chemistry
Molecular Weight
6045.7720
LogP
-29.2269
Drug-likeness
0.007
H-Bond Acceptors
89
H-Bond Donors
96
Rotatable Bonds
189
🔗 External References
HERB DB
PubChem CID
CAS Number
DrugBank
InChIKey
VBEQCZHXXJYVRD-GACYYNSASA-N
0
Clinical Trials
7
Meta-Analyses
0
PubMed References
Top Conditions Studied with Urogastrone
Diabetic foot ulcers are neurovascular complications of diab 1
Advanced non-small cell lung cancer (NSCLC) 1
the two most common epidermal growth factor receptor mutated 1
Skin toxicity induced by EGFR inhibitors 1
More than 50% of SCCHN (squamous cell carcinoma of the head 1
Metastatic HER2-positive breast cancer 1
Healing of lower limb ulcers in diabetic patients through th 1
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42019131970
Systematic review and planned meta-analysis of controlled clinical trials to examine clinical efficacy and safety of treatment with small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in comparison with control group in patients with metastatic human epidermal growth factor receptor (HER)2-positive breast cancer
Metastatic HER2-positive breast cancer
CRD42020162429
Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor monotherapy for advanced epidermal growth factor receptor mutated non-small cell lung cancer: a systematic review and meta-analysis
Advanced non-small cell lung cancer (NSCLC)
CRD42020163678
The efficacy of first line treatment of the two most common epidermal growth factor receptor mutated types, advanced non-small cell lung cancer
the two most common epidermal growth factor receptor mutated types(exon 19 delet
CRD42018087444
The efficacy of recombinant epidermal growth factor in the treatment of patients with diabetic foot ulcer compared to control (cure, debridement and antibiotic): systematic review of randomized clinical trials
Healing of lower limb ulcers in diabetic patients through the intralesioanal app
CRD42019126404
Epidermal growth factor in treatment of diabetic foot ulcer: meta-analysis and systematic review
Diabetic foot ulcers are neurovascular complications of diabetes mellitus. Among
CRD42021227004
Efficacy and safety of vitamin K in the prevention and treatment of skin toxicity induced by EGFR (epidermal growth factor receptor) -inhibitors: a Meta-analysis and systematic review
Skin toxicity induced by EGFR inhibitors
📚 Sample References
None linked yet.